Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

NCT04652570 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor change

Conditions

Membranous Nephropathy

Interventions

DRUG: VB119

Sponsor

Tenet Medicines